Method of Treating Inflammatory Bowel Disease with a Combination Therapy of Antibodies to IL-23 and TNF Alpha | Patent Publication Number 20220372129
US 20220372129 A1Publication DateNov 24, 2022
Original Assignee
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsChristopher O'Brien
Jacqueline Perrigoue
Marion Vetter
Matthew Germinaro
Jacqueline Perrigoue
Marion Vetter
Matthew Germinaro
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.